Results 81 to 90 of about 30,367 (239)
(a) Shows a three‐dimensional diagram of the mean GMFM‐66 score difference (after 6 month) as a function of the patient's age (in years) and the initial value of the GMFM‐66 score. (b) Shows a three‐dimensional diagram of the standard deviation of the GMFM‐66 score difference as a function of the patient's age (in years) and the initial value of the ...
Ibrahim Duran +6 more
wiley +1 more source
POLG1 Mutations and Charcot-Marie-Tooth Disease
A 35-year-old man first diagnosed with autosomal recessive Charcot-Marie-Tooth disease type 2 at 22 years of age had an abnormal gait and pes cavus at age 10 years.
J Gordon Millichap
doaj +1 more source
A Rare Case of Charcot-Mari-Tooth Disease Type 2S in a 20-year-old Man [PDF]
Charcot-Marie-Tooth disease type 2 (CMT2S) is rare form of Charcot-Marie-Tooth disease (CMT) that is characterized by a mutation in the IGHMBP2 gene. This gene encodes a helicase superfamily member that binds a specific DNA sequence from the region of ...
Natalia A. Shnayder +4 more
doaj +1 more source
Glutathione-conjugating and membrane-remodeling activity of GDAP1 relies on amphipathic C-terminal domain [PDF]
Mutations in the ganglioside-induced differentiation associated protein 1 (GDAP1) cause severe peripheral motor and sensory neuropathies called Charcot-Marie-Tooth disease.
Berger, Imre +6 more
core +2 more sources
A nonsense mutation in
Zeinab Jamiri +4 more
openalex +1 more source
CMT subtypes and disease burden in patients enrolled in the Inherited Neuropathies Consortium natural history study: a cross-sectional analysis [PDF]
BACKGROUND: The international Inherited Neuropathy Consortium (INC) was created with the goal of obtaining much needed natural history data for patients with Charcot-Marie-Tooth (CMT) disease.
Bacon, C +26 more
core +1 more source
Novel mutations expand the clinical spectrum of DYNC1H1-associated spinal muscular atrophy [PDF]
OBJECTIVE To expand the clinical phenotype of autosomal dominant congenital spinal muscular atrophy with lower extremity predominance (SMA-LED) due to mutations in the dynein, cytoplasmic 1, heavy chain 1 (DYNC1H1) gene.
Al-Lozi, Muhammad T +33 more
core +1 more source
ABSTRACT Background Mitofusin 2 (MFN2) is a major causative gene for axonal Charcot – Marie – Tooth disease type 2A (CMT2A), with a wide phenotypic spectrum. Comprehensive large ‐ scale genotype – phenotype association studies are essential for understanding disease pathogenesis and improved clinical management.
Masahiro Ando +13 more
wiley +1 more source
We report a 14-month-old toddler admitted to the Pediatric Oncology Department after surgical resection of supratentorial anaplastic ependymoma. The child was treated with International Society of Pediatric Oncology Ependymoma II 2015 chemotherapy ...
Maria Gogou +6 more
doaj +1 more source
ALS5/SPG11/KIAA1840 mutations cause autosomal recessive axonal Charcot-Marie-Tooth disease [PDF]
Charcot-Marie-Tooth disease is a group of hereditary peripheral neuropathies that share clinical characteristics of progressive distal muscle weakness and atrophy, foot deformities, distal sensory loss, as well as diminished tendon reflexes.
Barsottini O. G. P. +13 more
core +2 more sources

